MARINUS PHARMACEUTICALS, INC. Annual Depreciation in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Marinus Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from 2015 to 2023.
  • Marinus Pharmaceuticals, Inc. Depreciation for the quarter ending March 31, 2024 was $131K, a 16.6% decline year-over-year.
  • Marinus Pharmaceuticals, Inc. annual Depreciation for 2023 was $551K, a 31.8% increase from 2022.
  • Marinus Pharmaceuticals, Inc. annual Depreciation for 2022 was $418K, a 17.7% increase from 2021.
  • Marinus Pharmaceuticals, Inc. annual Depreciation for 2021 was $355K, a 6.29% increase from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $551K +$133K +31.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-05
2022 $418K +$63K +17.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-05
2021 $355K +$21K +6.29% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 $334K +$56K +20.1% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-24
2019 $278K +$151K +119% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-09
2018 $127K +$1K +0.79% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-16
2017 $126K +$103K +448% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-12
2016 $23K +$12K +109% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-12
2015 $11K Jan 1, 2015 Dec 31, 2015 10-K 2018-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.